
Oxford’s Lassa fever vaccine administered in trial
The first volunteer has been dosed in a first-in-human trial of the Lassa vaccine, marking an unprecedented step towards treating Lassa fever. The vaccine, developed by the University of Oxford, is being assessed for its safety and the immune response it triggers in volunteers. Thirty-one people aged… Read More







